Metraipolis › archive › dc_893b0bc6437d

Safety, In Vivo Fate, and Degradation of MOF Nanomedicines: Toward Translational Evaluation — Europe PMC PMID:42198242

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42198242
DOI
10.3390/pharmaceutics18050548
License (as archived)
solo-consultazione
Archived
2026-11-03T01:35:57.001Z
SHA-256 of the archived text
25e3a84d4497b8f04b5c2a05d34e049e40bec728663338bed632d7b4ac73db79
Stable URL of this page
https://metraipolis.com/documento/dc_893b0bc6437d

How to cite

Safety, In Vivo Fate, and Degradation of MOF Nanomedicines: Toward Translational Evaluation — Europe PMC PMID:42198242 — Europe PMC (en), https://europepmc.org/article/MED/42198242 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_893b0bc6437d (Metraipolis archive dc_893b0bc6437d, sha256 25e3a84d4497b8f04b5c2a05d34e049e40bec728663338bed632d7b4ac73db79)
BibTeX
@misc{dc893b0bc6437d,
  title = {Safety, In Vivo Fate, and Degradation of MOF Nanomedicines: Toward Translational Evaluation — Europe PMC PMID:42198242},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42198242},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_893b0bc6437d; sha256 25e3a84d4497b8f04b5c2a05d34e049e40bec728663338bed632d7b4ac73db79},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42198242. Agents can read the archived copy with the MCP tool read_document.